News & Research

Loading...

Fundswire

Loading...

Asset Classes A-Z
View funds in this asset class

News & Research

PIMCO

Schroder’s Kirrage: When there is no longer any evidence a stock can deliver, we sell it to growth managers

Matteo Anelli
28 February 2025
The manager describes what value investing means for him.

Innovation fuels biotech optimism

Ailsa Craig and Marek Poszepczynski
28 February 2025
Overall, we have a positive view on the biotech sector as we enter 2025.

Fundswire

Performance Tables

Data provided by FE fundinfo. Care has been taken to ensure that the information is correct, but FE fundinfo neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.